-
Je něco špatně v tomto záznamu ?
Differential expression of microRNAs in CD34+ cells of 5q- syndrome
H. Votavova, M. Grmanova, M. Dostalova Merkerova, M. Belickova, A. Vasikova, R. Neuwirtova, J. Cermak,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
BioMedCentral
od 2008-12-01
BioMedCentral Open Access
od 2008
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Medline Complete (EBSCOhost)
od 2009-01-17
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
Springer Nature OA/Free Journals
od 2008-12-01
PubMed
21211043
DOI
10.1186/1756-8722-4-1
Knihovny.cz E-zdroje
- MeSH
- antigeny CD34 biosyntéza genetika MeSH
- chromozomální delece MeSH
- lidé MeSH
- lidské chromozomy, pár 5 genetika metabolismus MeSH
- makrocytární anemie genetika metabolismus MeSH
- mikro RNA biosyntéza genetika MeSH
- myelodysplastické syndromy genetika metabolismus MeSH
- stanovení celkové genové exprese MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Myelodysplastic syndrome with isolated chromosome 5q deletion (5q- syndrome) is a clonal stem cell disorder characterized by ineffective hematopoiesis. MicroRNAs (miRNAs) are important regulators of hematopoiesis and their aberrant expression was detected in some clonal hematopoietic disorders. We thus analyzed miRNA expressions in bone marrow CD34+ cells of 5q- syndrome patients. Further, we studied gene expressions of miR-143, miR-145, miR-378 and miR-146a mapped within the 5q deletion. RESULTS: Using microarrays we identified 21 differently expressed miRNAs in 5q- patients compared to controls. Especially, miR-34a was markedly overexpressed in 5q- patients, suggesting its role in an increased apoptosis of bone marrow progenitors. Out of four miRNAs at del(5q), only miR-378 and miR-146a showed reduced gene expression in the patients. An integrative analysis of mRNA profiles and predicted putative targets defined potential downstream targets of the deregulated miRNAs. The list of targets included several genes that play an important role in the regulation of hematopoiesis (e.g. KLF4, LEF1, SPI1). CONCLUSIONS: The study demonstrates global overexpression of miRNAs is associated with 5q- phenotype. Identification of hematopoiesis-relevant target genes indicates that the deregulated miRNAs may be involved in the pathogenesis of 5q- syndrome by a modulation of these targets. The expression data on miRNAs at del(5q) suggest the presence of mechanisms for compensation of a gene dosage.
Department of Molecular Genetics Institute of Hematology and Blood Transfusion Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027889
- 003
- CZ-PrNML
- 005
- 20121207115921.0
- 007
- ta
- 008
- 120817e20110106enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1186/1756-8722-4-1 $2 doi
- 035 __
- $a (PubMed)21211043
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Votavova, Hana $u Department of Molecular Genetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic. Hana.Bruchova@uhkt.cz
- 245 10
- $a Differential expression of microRNAs in CD34+ cells of 5q- syndrome / $c H. Votavova, M. Grmanova, M. Dostalova Merkerova, M. Belickova, A. Vasikova, R. Neuwirtova, J. Cermak,
- 520 9_
- $a BACKGROUND: Myelodysplastic syndrome with isolated chromosome 5q deletion (5q- syndrome) is a clonal stem cell disorder characterized by ineffective hematopoiesis. MicroRNAs (miRNAs) are important regulators of hematopoiesis and their aberrant expression was detected in some clonal hematopoietic disorders. We thus analyzed miRNA expressions in bone marrow CD34+ cells of 5q- syndrome patients. Further, we studied gene expressions of miR-143, miR-145, miR-378 and miR-146a mapped within the 5q deletion. RESULTS: Using microarrays we identified 21 differently expressed miRNAs in 5q- patients compared to controls. Especially, miR-34a was markedly overexpressed in 5q- patients, suggesting its role in an increased apoptosis of bone marrow progenitors. Out of four miRNAs at del(5q), only miR-378 and miR-146a showed reduced gene expression in the patients. An integrative analysis of mRNA profiles and predicted putative targets defined potential downstream targets of the deregulated miRNAs. The list of targets included several genes that play an important role in the regulation of hematopoiesis (e.g. KLF4, LEF1, SPI1). CONCLUSIONS: The study demonstrates global overexpression of miRNAs is associated with 5q- phenotype. Identification of hematopoiesis-relevant target genes indicates that the deregulated miRNAs may be involved in the pathogenesis of 5q- syndrome by a modulation of these targets. The expression data on miRNAs at del(5q) suggest the presence of mechanisms for compensation of a gene dosage.
- 650 _2
- $a makrocytární anemie $x genetika $x metabolismus $7 D000748
- 650 _2
- $a antigeny CD34 $x biosyntéza $x genetika $7 D018952
- 650 _2
- $a chromozomální delece $7 D002872
- 650 _2
- $a lidské chromozomy, pár 5 $x genetika $x metabolismus $7 D002895
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x biosyntéza $x genetika $7 D035683
- 650 _2
- $a myelodysplastické syndromy $x genetika $x metabolismus $7 D009190
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Grmanova, Martina
- 700 1_
- $a Dostalova Merkerova, Michaela
- 700 1_
- $a Belickova, Monika
- 700 1_
- $a Vasikova, Alzbeta
- 700 1_
- $a Neuwirtova, Radana
- 700 1_
- $a Cermak, Jaroslav
- 773 0_
- $w MED00165458 $t Journal of hematology & oncology $x 1756-8722 $g Roč. 4(20110106), s. 1
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21211043 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207115955 $b ABA008
- 999 __
- $a ok $b bmc $g 949931 $s 785235
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 4 $d 1 $e 20110106 $i 1756-8722 $m Journal of hematology & oncology $n J Hematol Oncol $x MED00165458
- LZP __
- $a Pubmed-20120817/11/03